Jx Ddw
Jx Ddw

Swank Capital and Cushing® MLP Asset Management Announce Rebalancing of the Cushing® MLP High Income Index
DALLAS, April 5, 2012 /PRNewswire/ -- Swank Capital, LLC and Cushing® MLP Asset Management, LP announced today that the 30 members of the Cushing® MLP High Income Index will be rebalanced after the market close on April 13, 2012 as part of normal index operations.

AWM Investment Company, Inc.
NEW YORK, March 28, 2012 /PRNewswire/ - AWM Investment Company, Inc. ("AWM") announced today that three funds advised by it have acquired additional shares ("Shares") of Xebec Adsorption Inc. ("Xebec") in open market transactions. The three funds (the "Funds") are the Special Situations Fund III QP, L.P., the Special Situations Private Equity Fund, L.P., and the Special Situations Cayman Fund, L.P. On March 26, 2012, 42,000 Shares of Xebec at a price of CDN $0.15 per share were purchased by the Funds.

diaDexus, Inc. Highlights Findings from Two Outcomes Studies for its PLAC Lp-PLA(2) Activity Assay
SOUTH SAN FRANCISCO, Calif., March 19, 2012 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS), a company focused on proprietary cardiovascular diagnostic products, today highlighted data from two recent studies evaluating the clinical utility of its PLAC® Test for Lp-PLA(2)  Activity.

diaDexus Launches PLAC® Test for Lp-PLA(2) Activity in Europe
SOUTH SAN FRANCISCO, March 5, 2012 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS), a company focused on the development and commercialization of proprietary cardiovascular diagnostic products, today announced the commercial launch of its CE-marked PLAC® Test for Lp-PLA(2) Activity in Europe.





Privacy Policy | Copyright/Trademark Notification